Nigel C Phillips

This inventor holds 19 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Bioniche Life Sciences Inc., Bioniche Urology IP Inc., Bionicrie Life Sciences, Inc.. Active years: 2001-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nigel C Phillips. Retrieved from https://idiyas.com/inventor/nigel-c-phillips

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 2)

% Patents Active = 21.1

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 88(Granted Patents)

Location History:

Point-Claire, CA (2007 - 2008)
Pointe Claire, CA (2001 - 2015)

Company Filing History:

14 out of 18

Bioniche Life Sciences Inc.

patents

4 out of 4

Bioniche Urology IP Inc.

patents

1 out of 1

Bionicrie Life Sciences, Inc.

patent

Years Active: 2001-2015

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9220765 - Bacterial ribonucleic acid cell wall compositions and methods of making and using them (2015-12-29),

2. 9180177 - Bacterial ribonucleic acid cell wall compositions and methods of making and using them (2015-11-10),

3. 9180176 - Bacterial ribonucleic acid cell wall compositions and methods of making and using them (2015-11-10),

4. 9044422 - Bacterial ribonucleic acid cell wall compositions and methods of making and using them (2015-06-02),

5. 8350016 - Oligonucleotide compositions and their use to induce apoptosis (2013-01-08),

6. 7893242 - Oligonucleotide compositions and their use to induce apoptosis (2011-02-22),

7. 7662792 - Modulation of Fas and FasL expression (2010-02-16),

8. 7635686 - Therapeutically useful triethyleneglycol cholesteryl oligonucleotides (2009-12-22),

9. 7371734 - Oligonucleotide compositions and their use for the modulation of immune responses (2008-05-13),

10. 7200531 - Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides (2007-04-03),

11. 7199228 - Oligonucleotide compositions and their use to induce apoptosis (2007-04-03),

12. 7157436 - Therapeutically useful synthetic oligonucleotides (2007-01-02),

13. 7125858 - Hyaluronic acid in the treatment of cancer (2006-10-24),

14. 7087586 - Oligonucleotide compositions and their use to induce differentiation of cells (2006-08-08),

15. 6890911 - Method for the treatment of inflammation (2005-05-10),

Title: Nigel C. Phillips: Innovator in Bacterial Ribonucleic Acid Compositions

Introduction

Nigel C. Phillips is a prolific inventor based in Pointe-Claire, Canada, known for his impactful contributions to the field of biomedical sciences. With 19 patents to his name, he has made significant strides in developing novel compositions that have broad applications in health and medicine.

Latest Patents

Among his recent innovations, Phillips has developed a series of patents focusing on bacterial ribonucleic acid (RNA) cell wall compositions. His latest patent describes methods for creating these innovative compositions that contain RNA and components from bacterial and mycobacterial cell walls. Notably, these compositions exhibit immune-stimulating properties and anti-cancer activity, marking a breakthrough in therapeutic applications.

Career Highlights

Throughout his career, Phillips has been associated with prominent companies such as Bioniche Life Sciences Inc. and Bioniche Urology IP Inc. His work in these organizations involved extensive research and development efforts aimed at harnessing the therapeutic potentials of bacterial compositions for various medical applications.

Collaborations

Phillips has collaborated with esteemed colleagues, including Mario C. Filion and Zdenek Richard Holan. These partnerships have fostered innovative research approaches and have been instrumental in the advancement of their projects, contributing to Phillips' FDA-approved patents and significant scientific breakthroughs.

Conclusion

Nigel C. Phillips stands as a distinguished figure in the realm of inventions related to bacterial RNA compositions and their applications. His pioneering work continues to influence the field of biomedical research, offering new avenues for treatment and therapeutic development. As he progresses in his career, further contributions to science and medicine are anticipated from this innovative inventor.

Profile summary based on public USPTO records.